Search
                    New Orleans, LA Paid Clinical Trials
A listing of 459  clinical trials  in New Orleans, LA  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            397 - 408 of 459
        
                There are currently 459 clinical trials in New Orleans, Louisiana looking for participants to engage in research studies. Trials are conducted at various facilities, including Ochsner Clinic Foundation, Ochsner Medical Center Jefferson, Tulane University School of Medicine and University Medical Center New Orleans. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you. 
            
                                        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae
                                
            
            
        Recruiting
                            
            
                This prospective, global, multicenter, single arm post-approval study is designed to investigate the clinical use and safety of the Lutonix® 035 AV Drug Coated Balloon (DCB) PTA Catheter in subjects presenting with clinical and hemodynamic abnormalities in native arteriovenous (AV) fistulae located in the upper extremity.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                01/06/2025
            
            Locations: Ochsner Health System, New Orleans, Louisiana         
        
        
            Conditions: Arteriovenous Fistula
        
            
        
    
                
                                    CtDNA Based MRD Testing for NAC Monitoring in TNBC
                                
            
            
        Recruiting
                            
            
                A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided test to pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in stage I-III triple negative breast cancer (TNBC). Results from this study aim to improve MRD detection and disease outcomes for future patients.             
        
        
    Gender:
                FEMALE
            Ages:
                18 years and above
            Trial Updated:
                01/03/2025
            
            Locations: Louisiana State University, New Orleans, Louisiana         
        
        
            Conditions: TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
        
            
        
    
                
                                    Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
                                
            
            
        Recruiting
                            
            
                This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 yea...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 120 years
            Trial Updated:
                01/02/2025
            
            Locations: East Jefferson General Hospital, New Orleans, Louisiana  +2 locations         
        
        
            Conditions: Heart Diseases
        
            
        
    
                
                                    Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study
                                
            
            
        Recruiting
                            
            
                Demonstrating the pathophysiological link between Left Atrial (LA) and Left Atrial Appendage (LAA) pathology and embolic strokes in non-Atrial Fibrillation (AF) individuals represents a major advance in stroke prevention strategies. Instead of relying on non-specific criteria for stroke risk assessment, the investigators propose to identify individuals with high-risk of embolic stroke using imaging criteria that reflect the underlying pathophysiology of embolic stroke of cardiac origin. the inve...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 120 years
            Trial Updated:
                12/18/2024
            
            Locations: Tulane University Medical Center, New Orleans, Louisiana         
        
        
            Conditions: Atrial Fibrillation, Stroke, Stroke, Cardiovascular, Vascular Cognitive Impairment, Strokes Thrombotic, Stroke, Ischemic
        
            
        
    
                
                                    PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
                                
            
            
        Recruiting
                            
            
                The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population.
Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechograph...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 120 years
            Trial Updated:
                12/18/2024
            
            Locations: Tulane University Medical Center, New Orleans, Louisiana         
        
        
            Conditions: Valvular Heart Disease, Pericardial Disease, Cardiomyopathies
        
            
        
    
                
                                    The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study
                                
            
            
        Recruiting
                            
            
                The aim of the Correlation Of CoAGulation-Atrial Fibrillation (COAG-AF) study is to prove that an increase in pro-thrombotic biomarkers in AF is associated with an increase in AF burden.
Secondary objectives of the study are the following:
* To investigate the impact of catheter ablation on serum pro-thrombotic biomarkers in patients with AF.
* To correlate coagulation biomarkers with imaging features such as, the degree of fibrosis found on Late Gadolinium Enhancement Magnetic Resonance Imagi...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 120 years
            Trial Updated:
                12/18/2024
            
            Locations: Tulane University Medical Center, New Orleans, Louisiana         
        
        
            Conditions: Atrial Fibrillation
        
            
        
    
                
                                    Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
                                
            
            
        Recruiting
                            
            
                The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize that patients with a higher baseline Utah fibrosis staging will experience a higher incidence of POAF.
The study also aims to evaluate and compare the in-hospital mortality, length-of-stay (LOS), compl...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 40 years and 120 years
            Trial Updated:
                12/18/2024
            
            Locations: Tulane University Medical Center, New Orleans, Louisiana  +1 locations         
        
        
            Conditions: Atrial Fibrillation, Atrial Arrhythmia, Atrial Flutter, Atrial Tachycardia
        
            
        
    
                
                                    A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
                                
            
            
        Recruiting
                            
            
                This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.             
        
        
    Gender:
                FEMALE
            Ages:
                18 years and above
            Trial Updated:
                12/16/2024
            
            Locations: LSU Health New Orleans, New Orleans, Louisiana         
        
        
            Conditions: Cervical Cancer
        
            
        
    
                
                                    The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
                                
            
            
        Recruiting
                            
            
                The Achieve Trial is a randomized clinical trial to test whether lowering blood pressure to less than 140/90 mmHg in women with hypertensive disorders of pregnancy will prolong pregnancy.             
        
        
    Gender:
                FEMALE
            Ages:
                Between 14 years and 49 years
            Trial Updated:
                12/08/2024
            
            Locations: Oschner, New Orleans, Louisiana         
        
        
            Conditions: Preeclampsia, Gestational Hypertension, Hypertensive Disorder of Pregnancy
        
            
        
    
                
                                    Post-Market Study to Assess iTind Safety in Comparison to UroLift
                                
            
            
        Recruiting
                            
            
                The study objective is to evaluate the safety of the iTind device comparied to UroLift.             
        
        
    Gender:
                MALE
            Ages:
                50 years and above
            Trial Updated:
                12/05/2024
            
            Locations: Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana         
        
        
            Conditions: Benign Prostatic Hyperplasia (BPH)
        
            
        
    
                
                                    realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL
                                
            
            
        Recruiting
                            
            
                The realMIND study is a multicenter, observational study intended to further characterize the safety and effectiveness data of US patients (with a focus on racial and ethnic minority patients) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), treated with tafasitamab in combination with lenalidomide.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/05/2024
            
            Locations: Tulane Cancer Center, New Orleans, Louisiana         
        
        
            Conditions: Diffuse Large B-cell Lymphoma
        
            
        
    
                
                                    Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair
                                
            
            
        Recruiting
                            
            
                The aim of this study is to find out if using a certain kind of mesh can reduce the chances of hiatal hernias coming back after anti-reflux surgery. Participants undergoing antireflux surgery will be assigned to one of two groups, a group that has surgery with mesh, or a group that has surgery without mesh.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/02/2024
            
            Locations: Louisiana State University School of Medicine, New Orleans, Louisiana         
        
        
            Conditions: Hiatal Hernia
        
            
        
    397 - 408 of 459
            